Publisher Correction: Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs

In the version of this Article originally published, the author Peter Blume-Jensen was not denoted as a corresponding author; this has now been amended and the author’s email address has been added. The ‘Correspondence and requests for materials’ statement was similarly affected and has now been upd...

Full description

Saved in:
Bibliographic Details
Published inNature biomedical engineering Vol. 2; no. 9; p. 707
Main Authors Golder, Matthew R., Liu, Jenny, Andersen, Jannik N., Shipitsin, Michail V., Vohidov, Farrukh, Nguyen, Hung V.-T., Ehrlich, Deborah C., Huh, Sung Jin, Vangamudi, Bhavatarini, Economides, Kyriakos D., Neenan, Allison M., Ackley, James C., Baddour, Joelle, Paramasivan, Sattanathan, Brady, Samantha W., Held, Eric J., Reiter, Lawrence A., Saucier-Sawyer, Jennifer K., Kopesky, Paul W., Chickering, Donald E., Blume-Jensen, Peter, Johnson, Jeremiah A.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.09.2018
Nature Publishing Group
Subjects
14/4
59
639/925/352/152
692/4017
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Chemical compounds
Drugs
Fibrosis
Macromolecules
Prodrugs
Publisher Correction
Online AccessGet full text

Cover

More Information
Summary:In the version of this Article originally published, the author Peter Blume-Jensen was not denoted as a corresponding author; this has now been amended and the author’s email address has been added. The ‘Correspondence and requests for materials’ statement was similarly affected and has now been updated with the author’s initials ‘P.B-J.’
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:2157-846X
2157-846X
DOI:10.1038/s41551-018-0299-6